(Q37811459)

English

Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor

scientific article published on November 21, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor (English)

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Prudhviraju Dantuluri

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Biswarup Nanda

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Chennakesavulu Sidda

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Arehalli S. Manjappa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095210

31 August 2024

Kiran R. Chaudhari

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095210

31 August 2024

Makam P. Venkataraju

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095210

31 August 2024

Krutika K. Sawant

7

0000-0002-7716-2759

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095210

31 August 2024

Rayasa S. Ramachandra Murthy

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095210

31 August 2024

language of work or name

0 references

publication date

21 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S016836591000903X?httpAccept=text/xml

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

https://api.elsevier.com/content/article/PII:S016836591000903X?httpAccept=text/plain

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Journal of Controlled Release

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

150

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2-22

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Anticancer therapy using glucuronate modified long-circulating liposomes

1

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

2

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Serum opsonins and liposomes: their interaction and opsonophagocytosis

4

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Sterically stabilized liposomes

5

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Possibility of active targeting to tumor tissues with liposomes

7

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Immunoliposomes for the targeted delivery of antitumor drugs

8

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Continuous cultures of fused cells secreting antibody of predefined specificity

9

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Identification and validation of cell surface antigens for antibody targeting in oncology

11

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Antibody conjugates and therapeutic strategies

12

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Anatomy of the antibody molecule

15

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Simplified preparation of rabbit fab fragments

16

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses

17

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides

20

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments

21

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells

22

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Reaction of tobacco mosaic virus with a thiol-containing imidoester and a possible application to X-ray diffraction analysis

24

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Methyl 4-mercaptobutyrimidate as a cleavable crosslinking reagent and its application to the Escherichia coli 30S ribosome

25

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Addition of sulfhydryl groups of Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate)

26

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Activation of polysaccharides with 2-iminothiolane and its uses

27

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Topography of ribosomal proteins of the Escherichia coli 30S subunit as studied with the reversible cross-linking reagent methyl 4-mercaptobutyrimidate

28

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Subunit topography of RNA polymerase from Escherichia coli. A cross-linking study with bifunctional reagents

29

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Chemical cross-linking of chick oviduct progesterone-receptor subunits by using a reversible bifunctional cross-linking agent

30

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Use of maleimide-thiol coupling chemistry for efficient syntheses of oligonucleotide-enzyme conjugate hybridization probes

31

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

2-Iminothiolane: a reagent for the introduction of sulphydryl groups into oligosaccharides derived from asparagine-linked glycans

32

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Formation of N-substituted 2-iminothiolanes when amino groups in proteins and peptides are modified by 2-iminothiolane

33

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent

34

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

PEG-treated immunoliposomes specific for the Schwann cells of neural tissue

35

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Iodoacetylated and biotinylated liposomes: effect of spacer length on sulfhydryl ligand binding and avidin precipitability

36

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Preparation of immunoliposomes bearing poly(ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications

37

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.

39

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay

40

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Preparation and characterization of conjugates of recombinant CD4 and deglycosylated ricin A chain using different cross-linkers

42

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Syntaxin 16 and syntaxin 5 are required for efficient retrograde transport of several exogenous and endogenous cargo proteins

43

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall

44

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Introduction of sulfhydryl groups into proteins using acetylmercaptosuccinic anhydride

45

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

A method for the preparation of protein-protein conjugates of predetermined composition

46

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Covalent attachment of immunoglobulins to liposomes via glycosphingolipids

49

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Repulsive interactions and mechanical stability of polymer-grafted lipid membranes

52

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

53

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs).

54

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Radiation-guided targeting of combretastatin encapsulated immunoliposomes to mammary tumors.

55

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome

56

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity

57

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis

58

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Tumor targeting using anti-her2 immunoliposomes.

59

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Development of anti-p185HER2 immunoliposomes for cancer therapy

60

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

61

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library

62

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.

63

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer

64

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

65

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

3-(2-pyridyldithio)propionic acid hydrazide as a cross-linker in the formation of liposome-antibody conjugates

66

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes

67

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

A novel strategy affords high-yield coupling of antibody to extremities of liposomal surface-grafted PEG chains

68

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice

69

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

PEGylated immunoliposomes directed against brain astrocytes

71

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2

72

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).

74

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells

75

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro

76

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

A rapid and sensitive sub-micro phosphorus determination

77

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells

78

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

79

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells

80

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Targetability of novel immunoliposomes prepared by a new antibody conjugation technique

81

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome

82

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Stable target-sensitive immunoliposomes

83

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity

84

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

85

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

86

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups

87

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes

88

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Ligand-targeted liposomal anticancer drugs

89

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases

90

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Enzyme-based detection of glycoproteins on blot transfers using avidin-biotin technology

93

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Self-assembling cytotoxins

94

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Self-assembling drugs: a new approach to biochemical modulation in cancer chemotherapy

95

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Synergism through direct covalent bonding between agents: a strategy for rational design of chemotherapeutic combinations

96

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

p-Diazobenzoyl-biocytin: a new biotinylating reagent for DNA.

97

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Kilogram-scale synthesis of a second-generation dendrimer based on 1,3,5-triazine using green and industrially compatible methods with a single chromatographic step

98

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Sensory irritating properties of cyanuric chloride as revealed with plethysmographic method

99

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomes

102

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Targeted liposomes: A method for preparation and analysis

103

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Applications of single-chain variable fragment antibodies in therapeutics and diagnostics

105

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Antibody engineering

106

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

107

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Single-chain antigen-binding proteins

108

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Design and application of diabodies, triabodies and tetrabodies for cancer targeting

109

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

"Diabodies": small bivalent and bispecific antibody fragments

110

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Triabodies: single chain Fv fragments without a linker form trivalent trimers

111

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the V(L) domain of the scFv-0 (V(L)-V(H)) molecule is primarily responsible for formation of a tetramer-trimer equilibrium

112

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications

113

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.

114

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

115

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Phage display of antibody fragments.

116

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions

117

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs

118

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy

120

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

123

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Generation of immunoliposomes using recombinant single-chain Fv fragments bound to Ni-NTA-liposomes

124

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Novel single-chain Fv' formats for the generation of immunoliposomes by site-directed coupling

125

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Multiple site-specific in vitro labeling of single-chain antibody

126

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv

127

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Target ability and therapy efficacy of immunoliposomes using a humanized antihepatoma disulfide-stabilized Fv fragment on tumor cells

128

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in mice

129

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic

130

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Selection and characterization of HER2/neu-binding affibody ligands

132

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

133

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging

134

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer

135

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents

136

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL).

137

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

138

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome

139

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

140

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery

141

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

142

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes

143

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo.

144

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy

145

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro

146

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals

147

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice

148

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes

149

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo

150

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase

151

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis

152

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Grafting of different glycosides on the surface of liposomes and its effect on the tissue distribution of 125I-labelled γ-globulin encapsulated in liposomes

153

1 reference

10.1016/J.JCONREL.2010.11.002

https://api.crossref.org/works/10.1016/J.JCONREL.2010.11.002

31 August 2024

Identifiers

10.1016/J.JCONREL.2010.11.002

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37811459&oldid=2241012033"